Multiple Sclerosis clinical trials

178 recruiting studies in the US for multiple sclerosis, a disease affecting the brain and spinal cord.

Multiple sclerosis studies cover Phase 2 disease-modifying therapies, rehabilitation, exercise and imaging research, with many non-drug studies open to a broad range of people. Drug trials usually specify MS type — relapsing or progressive — and a disability score range. Recent relapses and current treatment can determine timing of enrollment.